The Omega-3 Index (percentage of EPA and DHA in red blood cell membranes) is a biomarker for omega-3 status. Some observational and interventional studies suggest that a higher Omega-3 Index is associated with improved insulin sensitivity and lower fasting blood glucose. However, the evidence is mixed: meta-analyses show modest positive effects on glycemic parameters in type 2 diabetes, but overall clinical effects are small to moderate. The Omega-3 Index is influenced by diet and genetics (e.g., FADS1 variants). A low index may indicate suboptimal intake, but raising it does not guarantee blood sugar improvement. The evidence level is 'human-moderate' – mechanistic and epidemiological support exists, but strong RCT evidence for direct glucose lowering is lacking. Caveat: Not a substitute for established diabetes management (diet, exercise, medication).
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-3f8a9a05ca0439add5b955cf